Delivering Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention in Opioid Use Disorder

NCT05053503 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

108

Enrollment

INDUSTRY

Sponsor class

Conditions

Opioid-use Disorder
Opioid Withdrawal

Interventions

DEVICE: Sparrow Ascent Therapy System
DRUG: Lofexidine
DRUG: Extended-release injectable naltrexone

Sponsor

Spark Biomedical, Inc.

Collaborators

[object Object]
[object Object]